AbstractProtein transduction domains (PTDs) are peptides that afford the internalization of cargo macromolecules (including plasmid DNA, proteins, liposomes, and nanoparticles). In the case of polycationic peptides, the efficiency of PTDs to promote cellular uptake is directly related to their molecular mass or their polyvalent presentation. Similarly, the efficiency of routing to the nucleus increases with the number of nuclear localization signals (NLS) associated with a cargo. The quantitative enhancement, however, depends on the identity of the PTD sequence as well as the targeted cell type. Thus the choice and multivalent presentation of PTD and NLS sequences are important criteria guiding the design of macromolecules intended for spec...
Currently, most of the commercially available therapeutics are all targeting cell surface receptors ...
Currently, most of the commercially available therapeutics are all targeting cell surface receptors ...
Along with steadily increasing interest in biopharmaceuticals such as peptides, proteins, or nucleic...
AbstractProtein transduction domains (PTDs) are peptides that afford the internalization of cargo ma...
SummaryProtein transduction domains (PTDs) are reagents that facilitate the delivery of diverse carg...
A cell delivery system is increasing in use in many areas of cell and molecular biology and bio-medi...
AbstractThe cellular delivery of therapeutic agents and their localization within cells is currently...
Protein transduction domains (PTDs) are powerful nongenetic tools that allow intracellular delivery ...
AbstractThe development of therapeutic peptides and proteins is limited by the poor permeability and...
The direct intracellular delivery of proteins has, until recently, been difficult to achieve, due pr...
In recent decades, the spectrum of available therapeutics has been expanded by the ever-growing fiel...
The lipid bilayer of a cell presents a significant barrier for the delivery of many molecular imagin...
Non-viral synthetic gene therapy reagents offer excellent structural and chemical versatility within...
Intracellular protein transduction technology is opening the door for a promising alternative to gen...
Transfection reagents are used to deliver DNA and siRNA into cells to achieve genetic manipulations,...
Currently, most of the commercially available therapeutics are all targeting cell surface receptors ...
Currently, most of the commercially available therapeutics are all targeting cell surface receptors ...
Along with steadily increasing interest in biopharmaceuticals such as peptides, proteins, or nucleic...
AbstractProtein transduction domains (PTDs) are peptides that afford the internalization of cargo ma...
SummaryProtein transduction domains (PTDs) are reagents that facilitate the delivery of diverse carg...
A cell delivery system is increasing in use in many areas of cell and molecular biology and bio-medi...
AbstractThe cellular delivery of therapeutic agents and their localization within cells is currently...
Protein transduction domains (PTDs) are powerful nongenetic tools that allow intracellular delivery ...
AbstractThe development of therapeutic peptides and proteins is limited by the poor permeability and...
The direct intracellular delivery of proteins has, until recently, been difficult to achieve, due pr...
In recent decades, the spectrum of available therapeutics has been expanded by the ever-growing fiel...
The lipid bilayer of a cell presents a significant barrier for the delivery of many molecular imagin...
Non-viral synthetic gene therapy reagents offer excellent structural and chemical versatility within...
Intracellular protein transduction technology is opening the door for a promising alternative to gen...
Transfection reagents are used to deliver DNA and siRNA into cells to achieve genetic manipulations,...
Currently, most of the commercially available therapeutics are all targeting cell surface receptors ...
Currently, most of the commercially available therapeutics are all targeting cell surface receptors ...
Along with steadily increasing interest in biopharmaceuticals such as peptides, proteins, or nucleic...